0001493152-19-019073.txt : 20191212 0001493152-19-019073.hdr.sgml : 20191212 20191212092914 ACCESSION NUMBER: 0001493152-19-019073 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20191212 FILED AS OF DATE: 20191212 DATE AS OF CHANGE: 20191212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biofrontera AG CENTRAL INDEX KEY: 0001712641 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38396 FILM NUMBER: 191281149 BUSINESS ADDRESS: STREET 1: HEMMELRATHER WEG 201 CITY: LEVERKUSEN STATE: 2M ZIP: D-51377 BUSINESS PHONE: 011 49 214 876 00 MAIL ADDRESS: STREET 1: HEMMELRATHER WEG 201 CITY: LEVERKUSEN STATE: 2M ZIP: D-51377 6-K 1 form6-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO

RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of December 2019

 

Commission File Number: 001-38396

 

BIOFRONTERA AG

(Registrant’s name / Translation of registrant’s name into English)

 

Hemmelrather Weg 201, D-51377 Leverkusen Germany

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [X] Form:40-F [  ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): N/A

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): N/A

 

 

 

 
 

 

EXHIBITS

 

Exhibit Number   Description
     
99.1  

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  BIOFRONTERA AG
   
  By: /s/ Hermann Lübbert
  Name: Hermann Lübbert
  Title: Chief Executive Officer

 

  By: /s/ Thomas Schaffer
  Name: Thomas Schaffer
  Title: Chief Financial Officer

 

Date: December 12, 2019

 

 
 

 

 EX-99.1 2 ex99-1.htm

 

Biofrontera AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 12.12.2019

 

1. Details of the person discharging managerial responsibilities / person closely associated

 

a) Name

 

Title:  
First name: Christoph
Last name(s): Dünwald

 

2. Reason for the notification

 

a) Position / status

 

Position: Member of the managing body

 

b) Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a) Name

 

Biofrontera AG

 

b) LEI

 

391200D6GFSVFGFQTL13

 

4. Details of the transaction(s)

 

a) Description of the financial instrument, type of instrument, identification code

 

Type: Share
ISIN: DE0006046113

 

b) Nature of the transaction

 

Acquisition

 

c) Price(s) and volume(s)

 

Price(s) Volume(s)
4.81 EUR 48100.00 EUR

 

d) Aggregated information

 

Price Aggregated volume
4.8100 EUR 48100.0000 EUR

 

e) Date of the transaction

 

2019-12-11; UTC+1

 

f) Place of the transaction

 

Name: Lang & Schwarz Wertpapierhandelsbank AG
MIC: LSSI

 

Company: Biofrontera AG
  Hemmelrather Weg 201
  51377 Leverkusen
  Germany
Internet: www.biofrontera.com